{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:37:22Z","timestamp":1790098642229,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12062-9","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:12:13Z","timestamp":1780733533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNA\u2013SIRT1 crosstalk in liver diseases: molecular regulation of metabolism, inflammation, and cell survival"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-5617","authenticated-orcid":false,"given":"Amr Ali Mohamed","family":"Abdelgawwad El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa H.","family":"Radhie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4146-6101","authenticated-orcid":false,"given":"Mirza R.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djaloliddin","family":"Mansurov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"M. M.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8421-3630","authenticated-orcid":false,"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Bainsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Jawad","family":"Alnajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"12062_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-023-01442-4","volume":"22","author":"Q Jin","year":"2024","unstructured":"Jin Q, Ma F, Liu T, Yang L, Mao H, Wang Y et al (2024) Sirtuins in kidney diseases: potential mechanism and therapeutic targets. Cell Commun Signal 22:114","journal-title":"Cell Commun Signal"},{"key":"12062_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/mrd.23437","volume":"87","author":"BN Vazquez","year":"2020","unstructured":"Vazquez BN, Vaquero A, Schindler K (2020) Sirtuins in female meiosis and in reproductive longevity. Mol Reprod Dev 87:1175\u20131187","journal-title":"Mol Reprod Dev"},{"key":"12062_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.124.325440","volume":"136","author":"YN Ding","year":"2025","unstructured":"Ding YN, Wang HY, Chen XF, Tang X, Chen HZ (2025) Roles of sirtuins in cardiovascular diseases: Mechanisms and therapeutics. Circ Res 136:524\u2013550","journal-title":"Circ Res"},{"key":"12062_CR4","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1002\/jcp.30772","volume":"237","author":"S Aggarwal","year":"2022","unstructured":"Aggarwal S, Trehanpati N, Nagarajan P, Ramakrishna G (2022) The Clock-NAD+\u2010Sirtuin connection in nonalcoholic fatty liver disease. J Cell Physiol 237:3164\u20133180","journal-title":"J Cell Physiol"},{"key":"12062_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cmet.2025.01.016","volume":"37","author":"J Jiang","year":"2025","unstructured":"Jiang J, Gao Y, Wang J, Huang Y, Yang R, Zhang Y et al (2025) Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism. Cell Metab 37:1119\u20131136 e13","journal-title":"Cell Metab"},{"key":"12062_CR6","doi-asserted-by":"publisher","first-page":"155285","DOI":"10.1016\/j.phymed.2023.155285","volume":"124","author":"J Liao","year":"2024","unstructured":"Liao J, Xie X, Wang N, Wang Y, Zhao J, Chen F et al (2024) Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway. Phytomedicine 124:155285","journal-title":"Phytomedicine"},{"key":"12062_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7150\/ijms.77955","volume":"20","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu J, Li P, Luo X, Zhang B (2023) Activating SIRT1 deacetylates NF-\u03baB p65 to alleviate liver inflammation and fibrosis via inhibiting NLRP3 pathway in macrophages. Int J Med Sci 20:505\u2013519","journal-title":"Int J Med Sci"},{"key":"12062_CR8","doi-asserted-by":"publisher","first-page":"156710","DOI":"10.1016\/j.phymed.2025.156710","volume":"141","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang Y, Zhao T, Zhou W, Khan A, Cao J et al (2025) 6\u2019-O-caffeoylarbutin attenuates D-galactose-induced brain and liver damage in aging mice via regulating SIRT1\/NF-\u03baB pathway. Phytomedicine 141:156710","journal-title":"Phytomedicine"},{"key":"12062_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7150\/ijms.77955","volume":"20","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu J, Li P, Luo X, Zhang B (2023) Activating SIRT1 deacetylates NF-\u03baB p65 to alleviate liver inflammation and fibrosis via inhibiting NLRP3 pathway in macrophages. Int J Med Sci 20:505","journal-title":"Int J Med Sci"},{"key":"12062_CR10","doi-asserted-by":"publisher","first-page":"104276","DOI":"10.1016\/j.phrs.2019.104276","volume":"146","author":"X Zhao","year":"2019","unstructured":"Zhao X, Jin Y, Li L, Xu L, Tang Z, Qi Y et al (2019) MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1. Pharmacol Res 146:104276","journal-title":"Pharmacol Res"},{"key":"12062_CR11","doi-asserted-by":"publisher","first-page":"156266","DOI":"10.1016\/j.metabol.2025.156266","volume":"169","author":"YH Lee","year":"2025","unstructured":"Lee YH, Lee J, Jeong J, Park K, Baik B, Kwon Y et al (2025) Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1. Metabolism 169:156266","journal-title":"Metabolism"},{"key":"12062_CR12","doi-asserted-by":"publisher","first-page":"156522","DOI":"10.1016\/j.phymed.2025.156522","volume":"139","author":"Q Ma","year":"2025","unstructured":"Ma Q, Huang S, Li MY, Luo QH, Chen FM, Hong CL et al (2025) Dihydromyricetin regulates the miR-155-5p\/SIRT1\/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury. Phytomedicine 139:156522","journal-title":"Phytomedicine"},{"key":"12062_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.32152","volume":"75","author":"R Ren","year":"2022","unstructured":"Ren R, He Y, Ding D, Cui A, Bao H, Ma J et al (2022) Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C\/EBP\u03b1-miRNA-223 axis. Hepatology 75:646\u2013660","journal-title":"Hepatology"},{"key":"12062_CR14","doi-asserted-by":"publisher","first-page":"100918","DOI":"10.1016\/j.jhepr.2023.100918","volume":"6","author":"R Rodr\u00edguez-Agudo","year":"2024","unstructured":"Rodr\u00edguez-Agudo R, Gonz\u00e1lez-Recio I, Serrano-Maci\u00e1 M, Bravo M, Petrov P, Blaya D et al (2024) Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. JHEP Rep 6:100918","journal-title":"JHEP Rep"},{"key":"12062_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.22753","volume":"35","author":"I El Shaffei","year":"2021","unstructured":"El Shaffei I, Abdel-Latif GA, Farag DB, Schaalan M, Salama RM (2021) Ameliorative effect of betanin on experimental cisplatin\u2010induced liver injury; the novel impact of miRNA\u201034a on the SIRT1\/PGC\u20101\u03b1 signaling pathway. J Biochem Mol Toxicol 35:1\u201314","journal-title":"J Biochem Mol Toxicol"},{"key":"12062_CR16","doi-asserted-by":"publisher","first-page":"22450","DOI":"10.1002\/jcp.28809","volume":"234","author":"S Han","year":"2019","unstructured":"Han S, Li Z, Ji P, Jia Y, Bai X, Cai W et al (2019) MCPIP1 alleviated lipopolysaccharide-induced liver injury by regulating SIRT1 via modulation of microRNA-9. J Cell Physiol 234:22450\u201322462","journal-title":"J Cell Physiol"},{"key":"12062_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","volume":"25","author":"JK Long","year":"2019","unstructured":"Long JK, Dai W, Zheng YW, Zhao SP (2019) miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med 25:26","journal-title":"Mol Med"},{"key":"12062_CR18","doi-asserted-by":"publisher","first-page":"22450","DOI":"10.1002\/jcp.28809","volume":"234","author":"S Han","year":"2019","unstructured":"Han S, Li Z, Ji P, Jia Y, Bai X, Cai W et al (2019) MCPIP1 alleviated lipopolysaccharide-induced liver injury by regulating SIRT1 via modulation of microRNA\u20109. J Cell Physiol 234:22450\u201322462","journal-title":"J Cell Physiol"},{"key":"12062_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.32152","volume":"75","author":"R Ren","year":"2022","unstructured":"Ren R, He Y, Ding D, Cui A, Bao H, Ma J et al (2022) Aging exaggerates acute-on\u2010chronic alcohol\u2010induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1\u2010C\/EBP\u03b1\u2010miRNA\u2010223 axis. Hepatology 75:646\u2013660","journal-title":"Hepatology"},{"key":"12062_CR20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/1440-1681.13273","volume":"47","author":"Y Li","year":"2020","unstructured":"Li Y, Shi H, Yuan J, Qiao L, Dong L, Wang Y (2020) Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of Sirtuin 7 via microRNA-3666. Clin Exp Pharmacol Physiol 47:1291\u20131300","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"12062_CR21","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1038\/onc.2013.216","volume":"33","author":"HJ Bae","year":"2014","unstructured":"Bae HJ, Noh JH, Kim JK, Eun JW, Jung KH, Kim MG et al (2014) MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma. Oncogene 33:2557\u20132567","journal-title":"Oncogene"},{"key":"12062_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/carcin\/bgac093","volume":"45","author":"D Yang","year":"2024","unstructured":"Yang D, Zhang P, Yang Z, Hou G, Yang Z (2024) miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Carcinogenesis 45:463\u2013474","journal-title":"Carcinogenesis"},{"key":"12062_CR23","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.3748\/wjg.v22.i46.10084","volume":"22","author":"F Nassir","year":"2016","unstructured":"Nassir F, Ibdah JA (2016) Sirtuins and nonalcoholic fatty liver disease. World J Gastroenterol 22:10084\u201310092","journal-title":"World J Gastroenterol"},{"key":"12062_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E (2015) NAD\u207a in aging, metabolism, and neurodegeneration. Science 350:1208\u20131213","journal-title":"Science"},{"key":"12062_CR25","doi-asserted-by":"publisher","first-page":"107155","DOI":"10.1016\/j.phrs.2024.107155","volume":"203","author":"C Tian","year":"2024","unstructured":"Tian C, Huang R, Xiang M (2024) SIRT1: Harnessing multiple pathways to hinder NAFLD. Pharmacol Res 203:107155","journal-title":"Pharmacol Res"},{"key":"12062_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12967-023-04790-4","volume":"21","author":"JW Yang","year":"2023","unstructured":"Yang JW, Zou Y, Chen J, Cui C, Song J, Yang MM et al (2023) Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis. J Transl Med 21:921","journal-title":"J Transl Med"},{"key":"12062_CR27","doi-asserted-by":"publisher","first-page":"107617","DOI":"10.1016\/j.phrs.2025.107617","volume":"212","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zheng Y, Shao M, Chen A, Liu M, Sun W et al (2025) AlphaFold-based AI docking reveals AMPK\/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease. Pharmacol Res 212:107617","journal-title":"Pharmacol Res"},{"key":"12062_CR28","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1002\/jcp.26896","volume":"234","author":"E Safarzadeh","year":"2019","unstructured":"Safarzadeh E, Hashemzadeh S, Duijf PHG, Mansoori B, Khaze V, Mohammadi A et al (2019) Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. J Cell Physiol 234:3515\u20133525","journal-title":"J Cell Physiol"},{"key":"12062_CR29","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.7150\/ijbs.49535","volume":"16","author":"R Ren","year":"2020","unstructured":"Ren R, Wang Z, Wu M, Wang H (2020) Emerging roles of SIRT1 in alcoholic liver disease. Int J Biol Sci 16:3174\u20133183","journal-title":"Int J Biol Sci"},{"key":"12062_CR30","doi-asserted-by":"crossref","unstructured":"de Gregorio E, Colell A, Morales A, Mar\u00ed M (2020) Relevance of SIRT1-NF-\u03baB Axis as therapeutic target to ameliorate inflammation in liver disease. Int J Mol Sci 21","DOI":"10.3390\/ijms21113858"},{"key":"12062_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature08778","volume":"464","author":"MD Hirschey","year":"2010","unstructured":"Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB et al (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121\u2013125","journal-title":"Nature"},{"key":"12062_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","volume":"77","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang Z, Bao R, Guo X, Gu Y, Yang W et al (2022) Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol 77:453\u2013466","journal-title":"J Hepatol"},{"key":"12062_CR33","doi-asserted-by":"publisher","first-page":"e2402710","DOI":"10.1002\/advs.202402710","volume":"11","author":"Q Yu","year":"2024","unstructured":"Yu Q, Zhang J, Li J, Song Y, Pan J, Mei C et al (2024) Sirtuin 5-Mediated Desuccinylation of ALDH2 Alleviates Mitochondrial Oxidative Stress Following Acetaminophen-Induced Acute Liver Injury. Adv Sci (Weinh) 11:e2402710","journal-title":"Adv Sci (Weinh)"},{"key":"12062_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2024.10.010","volume":"15","author":"A Zhuge","year":"2025","unstructured":"Zhuge A, Li S, Han S, Yuan Y, Shen J, Wu W et al (2025) Akkermansia muciniphila-derived acetate activates the hepatic AMPK\/SIRT1\/PGC-1\u03b1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease. Acta Pharm Sin B 15:151\u2013167","journal-title":"Acta Pharm Sin B"},{"key":"12062_CR35","doi-asserted-by":"publisher","first-page":"1548015","DOI":"10.3389\/fcell.2025.1548015","volume":"13","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gong C, Tao L, Zhai J, Huang F, Zhang S (2025) Involvement of SIRT1-mediated aging in liver diseases. Front Cell Dev Biol 13:1548015","journal-title":"Front Cell Dev Biol"},{"key":"12062_CR36","doi-asserted-by":"publisher","first-page":"121280","DOI":"10.1016\/j.lfs.2022.121280","volume":"313","author":"NF Abo El-Magd","year":"2023","unstructured":"Abo El-Magd NF, El-Kashef DH, El-Sherbiny M, Eraky SM (2023) Hepatoprotective and cognitive-enhancing effects of hesperidin against thioacetamide-induced hepatic encephalopathy in rats. Life Sci 313:121280","journal-title":"Life Sci"},{"key":"12062_CR37","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","volume":"43","author":"V Singh","year":"2020","unstructured":"Singh V, Ubaid S (2020) Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation. Inflammation 43:1589\u20131598","journal-title":"Inflammation"},{"key":"12062_CR38","doi-asserted-by":"publisher","first-page":"e23326","DOI":"10.1002\/jbt.23326","volume":"37","author":"S \u00c7omakl\u0131","year":"2023","unstructured":"\u00c7omakl\u0131 S, \u00d6zdemir S, K\u00fc\u00e7\u00fckler S, Kandemir FM (2023) Beneficial effects of quercetin on vincristine-induced liver injury in rats: Modulating the levels of Nrf2\/HO-1, NF-kB\/STAT3, and SIRT1\/PGC-1\u03b1. J Biochem Mol Toxicol 37:e23326","journal-title":"J Biochem Mol Toxicol"},{"key":"12062_CR39","doi-asserted-by":"crossref","unstructured":"Williams SN, Ding WX (2025) The impact of aging on liver health and the development of liver diseases. Hepatol Commun 9","DOI":"10.1097\/HC9.0000000000000808"},{"key":"12062_CR40","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.7150\/ijbs.117669","volume":"21","author":"F Zuo","year":"2025","unstructured":"Zuo F, Yang J, Wu Q, Yang Y, Zhou H, Sun Y et al (2025) SIRT1 in liver diseases: Mechanistic insights and therapeutic prospects. Int J Biol Sci 21:7086\u20137103","journal-title":"Int J Biol Sci"},{"key":"12062_CR41","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.18632\/aging.203920","volume":"15","author":"J Gong","year":"2023","unstructured":"Gong J, Cong M, Wu H, Wang M, Bai H, Wang J et al (2023) P53\/miR-34a\/SIRT1 positive feedback loop regulates the termination of liver regeneration. Aging 15:1859\u20131877","journal-title":"Aging"},{"key":"12062_CR42","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.phymed.2024.155533","volume":"128","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, He Y, Wang L, Xu H, Zhang Q, Wang Y et al (2024) Dihydroquercetin improves experimental acute liver failure by targeting ferroptosis and mitochondria-mediated apoptosis through the SIRT1\/p53 axis. Phytomedicine 128:155533","journal-title":"Phytomedicine"},{"key":"12062_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biomedicines14010151","volume":"14","author":"I Tsomidis","year":"2026","unstructured":"Tsomidis I, Tsakou A, Voumvouraki A, Kouroumalis E (2026) The role of kupffer cells and liver macrophages in the pathogenesis of metabolic dysfunction-associated steatotic liver disease. Biomedicines 14:151","journal-title":"Biomedicines"},{"key":"12062_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12944-024-02396-3","volume":"24","author":"S Gurjar","year":"2025","unstructured":"Gurjar S, Bhat AR, Upadhya R, Shenoy RP (2025) Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective. Lipids Health Dis 24:5","journal-title":"Lipids Health Dis"},{"key":"12062_CR45","doi-asserted-by":"crossref","unstructured":"Tao Q, Xie J, Zhou Y, Wu Y, Xia H, Wang J et al (2025) High-fat diet mediates the formation of nonalcoholic fatty liver by modulating the AhR\/miR-132\/SIRT1 axis. J Nutr Biochem 110174","DOI":"10.1016\/j.jnutbio.2025.110174"},{"key":"12062_CR46","doi-asserted-by":"publisher","first-page":"119030","DOI":"10.1016\/j.jep.2024.119030","volume":"338","author":"M Liang","year":"2025","unstructured":"Liang M, Xiao X, Chen M, Guo Y, Han W, Min Y et al (2025) Artemisia capillaris Thunb. Water extract alleviates metabolic dysfunction-associated Steatotic liver disease Disease by inhibiting miR-34a-5p to activate Sirt1-mediated hepatic lipid metabolism. J Ethnopharmacol 338:119030","journal-title":"J Ethnopharmacol"},{"key":"12062_CR47","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jcp.29002","volume":"235","author":"Z Yousefi","year":"2020","unstructured":"Yousefi Z, Nourbakhsh M, Abdolvahabi Z, Ghorbanhosseini SS, Hesari Z, Yarahmadi S et al (2020) microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1\/AMP\u2010activated protein kinase pathway in hepatocytes. J Cell Physiol 235:880\u2013890","journal-title":"J Cell Physiol"},{"key":"12062_CR48","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/osp4.70007","volume":"10","author":"N Dadkhah Nikroo","year":"2024","unstructured":"Dadkhah Nikroo N, Jafarinejad H, Yousefi Z, Abdolvahabi Z, Malek M, Mortazavi P et al (2024) Elevated mir-141 in obesity: Insights into the interplay with sirtuin 1 and non\u2010alcoholic fatty liver disease. Obes Sci Pract 10:e70007","journal-title":"Obes Sci Pract"},{"key":"12062_CR49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-024-05283-8","volume":"22","author":"L Yang","year":"2024","unstructured":"Yang L, Liu S, He Y, Gan L, Ni Q, Dai A et al (2024) Exosomes regulate SIRT3-related autophagy by delivering miR-421 to regulate macrophage polarization and participate in OSA-related NAFLD. J Translational Med 22:475","journal-title":"J Translational Med"},{"key":"12062_CR50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cells8091053","volume":"8","author":"A Stacchiotti","year":"2019","unstructured":"Stacchiotti A, Grossi I, Garc\u00eda-G\u00f3mez R, Patel GA, Salvi A, Lavazza A et al (2019) Melatonin effects on non-alcoholic fatty liver disease are related to microRNA-34a-5p\/Sirt1 axis and autophagy. Cells 8:1053","journal-title":"Cells"},{"key":"12062_CR51","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.4254\/wjh.v16.i12.1468","volume":"16","author":"F Sch\u00fctz","year":"2024","unstructured":"Sch\u00fctz F, Longo L, Keingeski MB, Filippi-Chiela E, Uribe-Cruz C, \u00c1lvares-da-Silva MR (2024) Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model. World J Hepatol 16:1468","journal-title":"World J Hepatol"},{"key":"12062_CR52","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1002\/ptr.8528","volume":"39","author":"S Zhu","year":"2025","unstructured":"Zhu S, Xu W, Chen Z, Lei X, Guan F, Ge J (2025) Nuciferine exerts anti-inflammatory effects in mice with non\u2010alcoholic steatohepatitis by regulating the miR\u201023a\u20103p\u2010SIRT1\u2010NF\u2010\u03baB pathway and akkermansia muciniphila\u2010extracellular vesicles. Phytother Res 39:3508\u20133525","journal-title":"Phytother Res"},{"key":"12062_CR53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-019-01796-8","volume":"97","author":"AL Sim\u00e3o","year":"2019","unstructured":"Sim\u00e3o AL, Afonso MB, Rodrigues PM, Gama-Carvalho M, Machado MV, Cortez-Pinto H et al (2019) Skeletal muscle miR-34a\/SIRT1: AMPK axis is activated in experimental and human non-alcoholic steatohepatitis. J Mol Med 97:1113\u20131126","journal-title":"J Mol Med"},{"key":"12062_CR54","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1111\/jcmm.15212","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zeng Z, Guan L, Ao R (2020) GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA\u2010200 and the MAPK pathway. J Cell Mol Med 24:6107\u20136119","journal-title":"J Cell Mol Med"},{"key":"12062_CR55","doi-asserted-by":"crossref","unstructured":"Yang Y, Hu W, Wu Z, Chen M, Li H, Cui J et al (2026) Morin improves postoperative cognitive dysfunction by mediating the miR-138-5p\/SIRT1 axis to regulate ferroptosis. Sci Rep","DOI":"10.1038\/s41598-025-34240-8"},{"key":"12062_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/13813455.2022.2046106","volume":"130","author":"MN BinMowyna","year":"2024","unstructured":"BinMowyna MN, AlFaris NA, Al-Sanea EA, AlTamimi JZ, Aldayel TS (2024) Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a\/SIRT1 axis. Arch Physiol Biochem 130:300\u2013315","journal-title":"Arch Physiol Biochem"},{"key":"12062_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12944-022-01740-9","volume":"21","author":"X Yuan","year":"2022","unstructured":"Yuan X, Li Y, Wen S, Xu C, Wang C, He Y et al (2022) CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease. Lipids Health Dis 21:127","journal-title":"Lipids Health Dis"},{"key":"12062_CR58","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.jhepr.2022.100466","volume":"4","author":"NW Habash","year":"2022","unstructured":"Habash NW, Sehrawat TS, Shah VH, Cao S (2022) Epigenetics of alcohol-related liver diseases. JHEP Rep 4:100466","journal-title":"JHEP Rep"},{"key":"12062_CR59","doi-asserted-by":"publisher","first-page":"e0089","DOI":"10.1097\/HC9.0000000000000089","volume":"7","author":"Y Wan","year":"2023","unstructured":"Wan Y, Slevin E, Koyama S, Huang C-K, Shetty AK, Li X et al (2023) miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury. Hepatol Commun 7:e0089","journal-title":"Hepatol Commun"},{"key":"12062_CR60","doi-asserted-by":"crossref","unstructured":"Xu T-t, Pan Y, Jin Y, Ding Q-c, Cao F-w, Guo R et al (2025) MiR-743a-3p-mediated hepatic GSTM1 elimination aggravates acetaminophen-induced acute liver injury by inhibiting Sp1 nuclear translocation and SIRT1 expression. Free Radical Biology and Medicine","DOI":"10.1016\/j.freeradbiomed.2025.09.045"},{"key":"12062_CR61","doi-asserted-by":"publisher","first-page":"177609","DOI":"10.1016\/j.ejphar.2025.177609","volume":"997","author":"AA Raouf","year":"2025","unstructured":"Raouf AA, El-Kadem AH, Sokar SS, Oraby MA, El-Shitany NA (2025) Cilostazol attenuates cisplatin-induced acute liver injury by targeting the SIRT1\/AMPK\/PGC-1\u03b1 signaling pathway, with an impact on miRNA-34a. Eur J Pharmacol 997:177609","journal-title":"Eur J Pharmacol"},{"key":"12062_CR62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/toxsci\/kfz095","volume":"170","author":"X Liu","year":"2019","unstructured":"Liu X, Zhao H, Luo C, Du D, Huang J, Ming Q et al (2019) Acetaminophen responsive miR-19b modulates SIRT1\/Nrf2 signaling pathway in drug-induced hepatotoxicity. Toxicol Sci 170:476\u2013488","journal-title":"Toxicol Sci"},{"key":"12062_CR63","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.3390\/nu17213451","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y, Dong Y, Cao Z, Ji Y, Cheng X, Zheng X (2025) The multi-dimensional action map of resveratrol against alzheimer\u2019s disease: Mechanism integration and treatment strategy optimization. Nutrients 17:3451","journal-title":"Nutrients"},{"key":"12062_CR64","doi-asserted-by":"publisher","first-page":"e23635","DOI":"10.1002\/jbt.23635","volume":"38","author":"S Barangi","year":"2024","unstructured":"Barangi S, Mehri S, Moosavi Z, Yarmohammadi F, Hayes AW, Karimi G (2024) Melatonin attenuates liver injury in arsenic-treated rats: The potential role of the Nrf2\/HO\u20101, apoptosis, and miR\u201034a\/Sirt1\/autophagy pathways. J Biochem Mol Toxicol 38:e23635","journal-title":"J Biochem Mol Toxicol"},{"key":"12062_CR65","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/01480545.2025.2574393","volume":"49","author":"FA Gad","year":"2026","unstructured":"Gad FA, Emam MA, Abdelhameed AA, Khalil DM, Elgebaly EA, Bakhuraysah MM et al (2026) N-acetyl cysteine and vitamin E attenuate acrylamide-induced hepatotoxicity via regulation of miRNA-34a and P53\/Nrf2\/SIRT 1 signaling pathways. Drug Chem Toxicol 49:574\u2013585","journal-title":"Drug Chem Toxicol"},{"key":"12062_CR66","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1111\/jcmm.16766","volume":"25","author":"H Wang","year":"2021","unstructured":"Wang H, Wang Z, Wang Y, Li X, Yang W, Wei S et al (2021) miRNA-130b\u20105p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression. J Cell Mol Med 25:7381\u20137394","journal-title":"J Cell Mol Med"},{"key":"12062_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","volume":"70","author":"T Zhang","year":"2019","unstructured":"Zhang T, Hu J, Wang X, Zhao X, Li Z, Niu J et al (2019) MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway. J Hepatol 70:87\u201396","journal-title":"J Hepatol"},{"key":"12062_CR68","doi-asserted-by":"publisher","first-page":"111002","DOI":"10.1016\/j.intimp.2023.111002","volume":"124","author":"H Lu","year":"2023","unstructured":"Lu H, Zhang R, Zhang S, Li Y, Liu Y, Xiong Y et al (2023) HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis. Int Immunopharmacol 124:111002","journal-title":"Int Immunopharmacol"},{"key":"12062_CR69","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/bph.14573","volume":"176","author":"L Song","year":"2019","unstructured":"Song L, Chen TY, Zhao XJ, Xu Q, Jiao RQ, Li JM et al (2019) Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose\u2010induced liver fibrosis through suppressing miR\u201034a\/Sirt1\/p53 and TGF\u2010\u03b21\/Smads signalling. Br J Pharmacol 176:1619\u20131634","journal-title":"Br J Pharmacol"},{"key":"12062_CR70","doi-asserted-by":"publisher","first-page":"152876","DOI":"10.1016\/j.prp.2020.152876","volume":"216","author":"X Li","year":"2020","unstructured":"Li X, Zhang W, Xu K, Lu J (2020) miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1\/p53 signaling pathway. Pathology-Research Pract 216:152876","journal-title":"Pathology-Research Pract"},{"key":"12062_CR71","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1080\/15384101.2020.1843813","volume":"19","author":"H Karbasforooshan","year":"2020","unstructured":"Karbasforooshan H, Hayes AW, Mohammadzadeh N, Zirak MR, Karimi G (2020) The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy. Cell Cycle 19:3209\u20133221","journal-title":"Cell Cycle"},{"key":"12062_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnut.2019.00148","volume":"6","author":"M Farcas","year":"2019","unstructured":"Farcas M, Gavrea A-A, Gulei D, Ionescu C, Irimie A, Catana CS et al (2019) SIRT1 in the development and treatment of hepatocellular carcinoma. Front Nutr 6:148","journal-title":"Front Nutr"},{"key":"12062_CR73","first-page":"1938","volume":"41","author":"X Yan","year":"2019","unstructured":"Yan X, Liu X, Wang Z, Cheng Q, Ji G, Yang H et al (2019) MicroRNA\u2013486\u20135p functions as a tumor suppressor of proliferation and cancer stem\u2013like cell properties by targeting Sirt1 in liver cancer. Oncol Rep 41:1938\u20131948","journal-title":"Oncol Rep"},{"key":"12062_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/1354750X.2020.1854856","volume":"26","author":"H Xiang","year":"2021","unstructured":"Xiang H, Luo M, Hou P, Xiao Z, Huang Z, Feng Q et al (2021) miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1. Biomarkers 26:196\u2013206","journal-title":"Biomarkers"},{"key":"12062_CR75","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10528-023-10521-7","volume":"62","author":"L Qian","year":"2024","unstructured":"Qian L, Zhang Y, Wang G, Li B, Zhou H, Qiu J et al (2024) miR-29a-SIRT1-Wnt\/\u03b2-Catenin Axis regulates tumor progression and survival in hepatocellular carcinoma. Biochem Genet 62:1895\u20131913","journal-title":"Biochem Genet"},{"key":"12062_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2016.03.027","volume":"343","author":"Z Tian","year":"2016","unstructured":"Tian Z, Jiang H, Liu Y, Huang Y, Xiong X, Wu H et al (2016) MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. Exp Cell Res 343:135\u2013147","journal-title":"Exp Cell Res"},{"key":"12062_CR77","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3892\/or.2017.5782","volume":"38","author":"J Luo","year":"2017","unstructured":"Luo J, Chen P, Xie W, Wu F (2017) MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1. Oncol Rep 38:1067\u20131074","journal-title":"Oncol Rep"},{"key":"12062_CR78","doi-asserted-by":"crossref","unstructured":"Zhou J, Zhou W, Kong F, Xiao X, Kuang H, Zhu Y (2019) microRNA\u201334a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma Corrigendum in\/10.3892\/ol. 11048. Oncology letters 2017(14)6950-4","DOI":"10.3892\/ol.2019.11048"},{"key":"12062_CR79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41419-021-04491-0","volume":"13","author":"Z-b Dong","year":"2022","unstructured":"Dong Z-b, Wu H-m, He Y-c, Huang Z-t, Weng Y-h, Li H et al (2022) MiRNA-124-3p. 1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. Cell Death Dis 13:35","journal-title":"Cell Death Dis"},{"key":"12062_CR80","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.18632\/aging.101876","volume":"11","author":"Y Xu","year":"2019","unstructured":"Xu Y, Lai Y, Weng H, Tan L, Li Y, Chen G et al (2019) MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133\u2009+\u2009hepatocellular carcinoma cells by targeting SIRT1\/ROS\/JNK pathway. Aging 11:2551","journal-title":"Aging"},{"key":"12062_CR81","doi-asserted-by":"publisher","first-page":"121773","DOI":"10.1016\/j.lfs.2023.121773","volume":"325","author":"Z Hu","year":"2023","unstructured":"Hu Z, Zhao Y, Mang Y, Zhu J, Yu L, Li L et al (2023) MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24. Life Sci 325:121773","journal-title":"Life Sci"},{"key":"12062_CR82","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/21655979.2021.1920323","volume":"12","author":"W Song","year":"2021","unstructured":"Song W, Wenhui Z, Ruiqiang Y, Hu X, Shi T, Wang M et al (2021) Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1. Bioengineered 12:1599\u20131610","journal-title":"Bioengineered"},{"key":"12062_CR83","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1038\/s41598-019-43731-4","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhu Y, Hu L, Yan F, Chen J (2019) miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3\/TGF-\u03b2\/SMAD signaling pathway. Sci Rep 9:7213","journal-title":"Sci Rep"},{"key":"12062_CR84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11010-020-03815-6","volume":"473","author":"S-J Tang","year":"2020","unstructured":"Tang S-J, Yang J-B (2020) LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p\/SIRT5 pathway in hepatocellular carcinoma. Mol Cell Biochem 473:143\u2013153","journal-title":"Mol Cell Biochem"},{"key":"12062_CR85","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong H, Ni Z, He J, Jiang S, Li X, Gong W et al (2017) LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene 36:3528\u20133540","journal-title":"Oncogene"},{"key":"12062_CR86","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.18632\/aging.102240","volume":"11","author":"L Zhao","year":"2019","unstructured":"Zhao L, Hu K, Cao J, Wang P, Li J, Zeng K et al (2019) lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence. Aging 11:7098","journal-title":"Aging"},{"key":"12062_CR87","doi-asserted-by":"publisher","first-page":"101042831771813","DOI":"10.1177\/1010428317718135","volume":"39","author":"Z Hou","year":"2017","unstructured":"Hou Z, Xu X, Zhou L, Fu X, Tao S, Zhou J et al (2017) The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1. Tumor Biology 39:1010428317718135","journal-title":"Tumor Biology"},{"key":"12062_CR88","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3892\/ol.2020.11635","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, He M, Chen J, Li C, Zhang Q (2020) Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a\/SIRT1 axis in liver cancer. Oncol Lett 20:893\u2013901","journal-title":"Oncol Lett"},{"key":"12062_CR89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.46439\/signaling.3.060","volume":"3","author":"L Chen","year":"2025","unstructured":"Chen L, Lu Q, Yang T (2025) SIRT1-mediated deacetylation in MAFLD: Mechanisms and therapeutic implications. Cell Signal 3:69\u201375","journal-title":"Cell Signal"},{"key":"12062_CR90","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1038\/s41598-024-55923-8","volume":"14","author":"N Chang","year":"2024","unstructured":"Chang N, Li J, Lin S, Zhang J, Zeng W, Ma G et al (2024) Emerging roles of SIRT1 activator, SRT2104, in disease treatment. Sci Rep 14:5521","journal-title":"Sci Rep"},{"key":"12062_CR91","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/MIB.0000000000000597","volume":"22","author":"BE Sands","year":"2016","unstructured":"Sands BE, Joshi S, Haddad J, Freudenberg JM, Oommen DE, Hoffmann E et al (2016) Assessing colonic exposure, safety, and clinical activity of SRT2104, a novel oral SIRT1 activator, in patients with mild to moderate ulcerative colitis. Inflamm Bowel Dis 22:607\u2013614","journal-title":"Inflamm Bowel Dis"},{"key":"12062_CR92","doi-asserted-by":"publisher","first-page":"16756","DOI":"10.1038\/s41598-024-67882-1","volume":"14","author":"Z Hu","year":"2024","unstructured":"Hu Z, Cheng X, Cai J, Huang C, Hu J, Liu J (2024) Emodin alleviates cholestatic liver injury by modulating Sirt1\/Fxr signaling pathways. Sci Rep 14:16756","journal-title":"Sci Rep"},{"key":"12062_CR93","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.7150\/ijbs.97362","volume":"20","author":"W Nie","year":"2024","unstructured":"Nie W, Zhu H, Sun X, Zhou J, Xu H, Yu Z et al (2024) Catalpol attenuates hepatic glucose metabolism disorder and oxidative stress in triptolide-induced liver injury by regulating the SIRT1\/HIF-1\u03b1 pathway. Int J Biol Sci 20:4077\u20134097","journal-title":"Int J Biol Sci"},{"key":"12062_CR94","doi-asserted-by":"crossref","unstructured":"He X, Li Y, Deng X, Xiao X, Zeng J (2023) Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses. Front Pharmacol. Volume 14","DOI":"10.3389\/fphar.2023.1230783"},{"key":"12062_CR95","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","volume":"47","author":"S Chen","year":"2015","unstructured":"Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y et al (2015) Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Disease 47:226\u2013232","journal-title":"Dig Liver Disease"},{"key":"12062_CR96","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","volume":"34","author":"F Faghihzadeh","year":"2014","unstructured":"Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A (2014) Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res 34:837\u2013843","journal-title":"Nutr Res"},{"key":"12062_CR97","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3390\/ijms21113858","volume":"21","author":"E de Gregorio","year":"2020","unstructured":"de Gregorio E, Colell A, Morales A, Mar\u00ed M (2020) Relevance of SIRT1-NF-\u03baB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. Int J Mol Sci 21:3858","journal-title":"Int J Mol Sci"},{"key":"12062_CR98","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1002\/jcp.26743","volume":"233","author":"G Ghalamfarsa","year":"2018","unstructured":"Ghalamfarsa G, Rastegari A, Atyabi F, Hassannia H, Hojjat-Farsangi M, Ghanbari A et al (2018) Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice. J Cell Physiol 233:7165\u20137177","journal-title":"J Cell Physiol"},{"key":"12062_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1478-811X-9-11","volume":"9","author":"S Rahman","year":"2011","unstructured":"Rahman S, Islam R (2011) Mammalian Sirt1: insights on its biological functions. Cell Communication Signal 9:11","journal-title":"Cell Communication Signal"},{"key":"12062_CR101","doi-asserted-by":"publisher","first-page":"1571767","DOI":"10.3389\/fphar.2025.1571767","volume":"16","author":"D Ye","year":"2025","unstructured":"Ye D, Zhu J, Su S, Yu Y, Zhang J, Yin Y et al (2025) Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications. Front Pharmacol 16:1571767","journal-title":"Front Pharmacol"},{"key":"12062_CR102","first-page":"878","volume":"13","author":"H Zhang","year":"2025","unstructured":"Zhang H, Wu D, Wu Q, Wu Y, Guo Z, Wang L et al (2025) The Role of Hepatic SIRT1: From Metabolic Regulation to Immune Modulation and Multi-target Therapeutic Strategies. J Clin Translational Hepatol 13:878","journal-title":"J Clin Translational Hepatol"},{"key":"12062_CR103","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW et al (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948","journal-title":"Nat Commun"},{"key":"12062_CR104","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.7150\/ijbs.68873","volume":"18","author":"Q Li","year":"2022","unstructured":"Li Q, Tan J-X, He Y, Bai F, Li S-W, Hou Y-W et al (2022) Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway. Int J Biol Sci 18:1594","journal-title":"Int J Biol Sci"},{"key":"12062_CR105","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.3748\/wjg.v19.i46.8459","volume":"19","author":"K Tajiri","year":"2013","unstructured":"Tajiri K, Shimizu Y (2013) Liver physiology and liver diseases in the elderly. World J gastroenterology: WJG 19:8459","journal-title":"World J gastroenterology: WJG"},{"key":"12062_CR106","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.gastrohep.2022.12.003","volume":"46","author":"K Chen","year":"2023","unstructured":"Chen K, Lin T, Yao W, Chen X, Xiong X, Huang Z (2023) Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1. Gastroenterolog\u00eda y hepatolog\u00eda 46:531\u2013541","journal-title":"Gastroenterolog\u00eda y hepatolog\u00eda"},{"key":"12062_CR107","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/jcm10143011","volume":"10","author":"A Michalak","year":"2021","unstructured":"Michalak A, Lach T, Cicho\u017c-Lach H (2021) Oxidative stress\u2014a key player in the course of alcohol-related liver disease. J Clin Med 10:3011","journal-title":"J Clin Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12062-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:02:49Z","timestamp":1780736569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12062-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12062"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12062-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"There is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"899"}}